$BPTH 4 SEC Filings

Filed On	Filing
01 Aug 2024	Form 4: Sherwood Aline, Director Granted 2,000 Common Stock Option (right to buy)
01 Aug 2024	Form 4: Aubert Paul, Director Granted 2,000 Common Stock Option (right to buy)
01 Aug 2024	Form 4: Cleaver Heath, Director Granted 2,000 Common Stock Option (right to buy)
01 Aug 2024	Form 4: Morris Douglas P, Director Granted 3,537 Common Stock Option (right to buy)
01 Aug 2024	Form 4: Nielsen Peter Henry, Director Granted 25,000 Common Stock Option (right to buy)
04 May 2023	Form 4: Cleaver Heath, Director Granted 10,000 Common Stock Option (right to buy)
04 May 2023	Form 4: Aubert Paul, Director Granted 10,000 Common Stock Option (right to buy)
04 May 2023	Form 4: Sherwood Aline, Director Granted 10,000 Common Stock Option (right to buy)
04 May 2023	Form 4: Morris Douglas P, Director Granted 13,000 Common Stock Option (right to buy)
04 May 2023	Form 4: Nielsen Peter Henry, Director Granted 105,000 Common Stock Option (right to buy)
08 Apr 2022	Form 4: Sherwood Aline, Director Granted 10,000 Common Stock Option (right to buy)
30 Mar 2022	Form 4: Morris Douglas P, Director Granted 11,000 Common Stock Option (right to buy)
30 Mar 2022	Form 4: Cleaver Heath, Director Granted 10,000 Common Stock Option (right to buy)
30 Mar 2022	Form 4: Aubert Paul, Director Granted 10,000 Common Stock Option (right to buy)
25 Mar 2022	Form 4: Nielsen Peter Henry, Director Granted 90,000 Common Stock Option (right to buy)
31 Mar 2021	Form 4: Molsbergen Tamaro Martina, Director Granted 10,000 Common Stock Option (right to buy)
31 Mar 2021	Form 4: Aubert Paul, Director Granted 10,000 Common Stock Option (right to buy)
31 Mar 2021	Form 4: Cleaver Heath, Director Granted 10,000 Common Stock Option (right to buy)
31 Mar 2021	Form 4: Morris Douglas P, Director Granted 13,000 Common Stock Option (right to buy)
31 Mar 2021	Form 4: Nielsen Peter Henry, Director Granted 100,000 Common Stock Option (right to buy)

Comments